GTBP
GT Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GTBP fundamentals
GT Biopharma (GTBP) released its earnings on Aug 14, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.55 (YoY +74.65%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.55
+74.65%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
GT Biopharma (GTBP) key financial stats and ratios, covering profitability, financial health, and leverage.
GT Biopharma (GTBP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
GT Biopharma (GTBP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
GT Biopharma (GTBP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does GT Biopharma (GTBP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track GT Biopharma (GTBP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is GT Biopharma's gross profit margin?What factors drove the changes in GT Biopharma's revenue and profit?Did GT Biopharma beat or miss consensus estimates last quarter?What guidance did GT Biopharma's management provide for the next earnings period?What is the market's earnings forecast for GT Biopharma next quarter?What is the revenue and EPS growth rate for GT Biopharma year over year?What is GT Biopharma's latest dividend and current dividend yield?What were the key takeaways from GT Biopharma’s earnings call?
